Home / Market News / $MGRX
benzinga Corporate Catalyst Impact 85/100 ● positive

Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why

Aug 6, 2026, 5:19 AM UTC · Primary ticker $MGRX

Mangoceuticals (MGRX) shares surged after its merger partner's subsidiary, Nuclea Energy USA Inc., signed an MOU with Utah's Office of Energy Development to advance a nuclear test reactor. This development significantly de-risks the ongoing merger between Mangoceuticals and Nuclea Energy, which aims to bring Nuclea a Nasdaq listing.

Mangoceuticals (MGRX) experienced a significant after-hours jump due to a key development related to its pending merger with Nuclea Energy. Nuclea Energy USA Inc., a subsidiary of the merger partner, signed a Memorandum of Understanding (MOU) with Utah's Office of Energy Development to explore siting a nuclear test reactor. This MOU is crucial as it advances the development of Nuclea's Morpheus microreactor, adding substantial weight and credibility to the merger, which aims to give Nuclea a Nasdaq listing through MGRX. The news also comes alongside MGRX receiving a 180-day extension to regain Nasdaq compliance, further reducing immediate delisting pressure. For traders, this represents a short-term opportunity driven by positive news flow and reduced uncertainty surrounding the merger, potentially signaling a turnaround for a stock that has been trading near its annual low. The long-term implications depend on the successful completion of the merger and the commercialization potential of Nuclea's advanced nuclear technology.

$MGRX positive Merger progress and Nasdaq compliance extension
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.